UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 653

Sortiert nach

Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial

Neurology, 2012-04, Vol.78 (17), p.1315

2012

Link zum Volltext

Verfügbarkeit prüfen

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

Neurology, 2011-02, Vol.76 (8), p.686

2011

Link zum Volltext

Verfügbarkeit prüfen

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

Neurology, 2009-03, Vol.72 (9), p.800

2009

Link zum Volltext

Verfügbarkeit prüfen

The epidemiology of multiple sclerosis: insights to a causal cascade

Handbook of clinical neurology, 2016, Vol.138, p.173-206

Goodin, D S

2016

Link zum Volltext

Verfügbarkeit prüfen

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

Journal of neurology, neurosurgery and psychiatry, 2010-08, Vol.81 (8), p.907-912

2010

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Clinical Neurophysiology Society

Neurology, 2012-02, Vol.78 (8), p.585

2012

Link zum Volltext

Verfügbarkeit prüfen

Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions

BMC medical genomics, 2021-07, Vol.14 (1), p.183-183, Article 183

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode

Multiple sclerosis, 2009-10, Vol.15 (10), p.1175-1182

2009

Link zum Volltext

Verfügbarkeit prüfen

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Neurology, 2002-01, Vol.58 (2), p.169

2002

Link zum Volltext

Verfügbarkeit prüfen

Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2004-05, Vol.62 (9), p.1468

2004

Link zum Volltext

Verfügbarkeit prüfen

HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course

American journal of human genetics, 2003-03, Vol.72 (3), p.710-716

2003

Link zum Volltext

Verfügbarkeit prüfen

Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2008-09, Vol.71 (10), p.766

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

Neurology, 2004-12, Vol.63 (11), p.2039

2004

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2007-03, Vol.68 (13), p.977

2007

Link zum Volltext

Verfügbarkeit prüfen

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2003-11, Vol.61 (10), p.1332

2003

Link zum Volltext

Verfügbarkeit prüfen

Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures

Neurology, 2009-05, Vol.72 (20), p.1760

2009

Link zum Volltext

Verfügbarkeit prüfen

Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS

American journal of neuroradiology : AJNR, 2020-12, Vol.41 (12), p.2219-2226

2020

Link zum Volltext

Verfügbarkeit prüfen

Genotype-Phenotype Correlations in Multiple Sclerosis: "HLA" Genes Influence Disease Severity Inferred by [superscript 1]HMR Spectroscopy and MRI Measures

Brain (London, England : 1878), 2009-01, Vol.132 (1), p.250

2009

Link zum Volltext

Verfügbarkeit prüfen

IN34-TU-02 Therapeutic advances in multiple sclerosis

Journal of the neurological sciences, 2009, Vol.285, p.S26-S26

Goodin, D

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility of surface EMG: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology

Neurology, 2000-07, Vol.55 (2), p.171

2000

Link zum Volltext

Verfügbarkeit prüfen

The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2003-09, Vol.61 (5), p.602

2003

Link zum Volltext

Verfügbarkeit prüfen

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496

2002

Link zum Volltext

Verfügbarkeit prüfen

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS

Neurology, 2010-06, Vol.74 (23), p.1877

2010

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Defect Analysis of Ablator Capsule Surfaces Using a Leica Confocal Microscope and a High-Density Atomic Force Microscope

Fusion science and technology, 2016-09, Vol.70 (2), p.377-386

2016

Link zum Volltext

Verfügbarkeit prüfen

Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S

Multiple sclerosis and related disorders, 2014-05, Vol.3 (3), p.364-371

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 653

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(570)
Mit Volltextzugriff
(567)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(394)
Life Sciences & Biomedicine
(288)
Humans
(218)
Neurosciences & Neurology
(143)
Clinical Neurology
(125)
Male
(120)
Biological And Medical Sciences
(115)
Female
(112)
Adult
(99)
Middle Aged
(80)
Medical Sciences
(73)
Neurology
(68)
Technology
(67)
Neurosciences
(62)
Physical Sciences
(61)
Aged
(49)
Fundamental And Applied Biological Sciences. Psychology
(44)
Exact Sciences And Technology
(38)
Biochemistry & Molecular Biology
(36)
Physics
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

The epidemiology of multiple sclerosis: insights to a causal cascade

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Clinical Neurophysiology Society

Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions

Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course

Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures

Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS

Genotype-Phenotype Correlations in Multiple Sclerosis: "HLA" Genes Influence Disease Severity Inferred by [superscript 1]HMR Spectroscopy and MRI Measures

IN34-TU-02 Therapeutic advances in multiple sclerosis

Clinical utility of surface EMG: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology

The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS

Quantitative Defect Analysis of Ablator Capsule Surfaces Using a Leica Confocal Microscope and a High-Density Atomic Force Microscope

Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S

Suchergebnisse filtern